XML 13 R3.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Operations - USD ($)
shares in Millions, $ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Revenues:        
Premiums $ 77,442 $ 72,339 $ 232,327 $ 217,599
Investment and other income 1,643 997 3,651 2,910
Total revenues 100,820 92,361 299,471 277,195
Operating costs:        
Medical Costs 65,957 59,550 197,150 179,663
Operating costs 13,280 13,855 40,519 41,289
Cost of products sold 11,834 9,423 34,230 28,576
Depreciation and amortization 1,041 1,007 3,058 2,998
Total operating costs 92,112 83,835 274,957 252,526
Earnings from operations 8,708 8,526 24,514 24,669
Interest expense (1,074) (834) (2,903) (2,416)
Loss on sale of subsidiary and subsidiaries held for sale (20) 0 (8,331) 0
Earnings before income taxes 7,614 7,692 13,280 22,253
Provision for income taxes (1,356) (1,654) (3,822) (4,784)
Net earnings 6,258 6,038 9,458 17,469
Earnings attributable to noncontrolling interests (203) (197) (596) (543)
Net earnings attributable to UnitedHealth Group common shareholders $ 6,055 $ 5,841 $ 8,862 $ 16,926
Earnings per share attributable to UnitedHealth Group common shareholders:        
Basic $ 6.56 $ 6.31 $ 9.61 $ 18.20
Diluted $ 6.51 $ 6.24 $ 9.53 $ 18.01
Basic weighted-average number of common shares outstanding 923 926 922 930
Dilutive effect of common share equivalents 7 10 8 10
Diluted weighted-average number of common shares outstanding 930 936 930 940
Anti-dilutive shares excluded from the calculation of dilutive effect of common share equivalents 4 6 6 6
Products        
Revenues:        
Revenue from Products and Services $ 12,631 $ 10,354 $ 36,751 $ 31,272
Services        
Revenues:        
Revenue from Products and Services $ 9,104 $ 8,671 $ 26,742 $ 25,414